EDITAS MEDICINE, INC. Other Current Liabilities
EDITAS MEDICINE, INC. (EDIT) had Other Current Liabilities of $3.13 million as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2021-02-26
- 2020-09-30: Other Liabilities, Current $3.13M.
- 2020-06-30: Other Liabilities, Current $4.03M.
- 2020-03-31: Other Liabilities, Current $3.52M.
- 2019-12-31: Other Liabilities, Current $2.68M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2020-09-30 | $3.13M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $4.03M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.52M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $2.68M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $1.56M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.03M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.91M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $2.05M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $980.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $944.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $908.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $900.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $831.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.13M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $13.29M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $748.00K 10-K · filed 2018-03-08 | $986.00K 10-K · filed 2017-03-03 |
| 2016-09-30 | $547.00K 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |